Linked research, clinical, and regulatory source pathways.
Company profile
About Cyclica
CYCLICA operates as a comprehensive B2B marketplace specializing in used heavy equipment and construction machinery. The company provides a platform for buying and selling a wide range of industrial equipment including crawler excavators, wheel loaders, dumpers, paving equipment, engines, spare parts, elevation equipment, forklifts, and vehicles. CYCLICA differentiates itself through its quality certification program, where equipment undergoes inspection by technical specialists using over 150 verification points. The company emphasizes transparency, providing detailed technical specifications and verified information for all listed equipment. With an international presence across multiple countries including Spain, Italy, Serbia, Slovenia, Albania, Croatia, Portugal, Chile, Bosnia and Herzegovina, Macedonia, Montenegro, USA, Dominican Republic, Netherlands, and Saudi Arabia, CYCLICA offers global distribution services. The platform maintains an extensive inventory of over 450 references and 6,675 products, with a significant focus on Caterpillar equipment and parts. CYCLICA's business model is built on four foundational principles: competence through experienced professionals, rigor based on data and verified information, transparency in all transactions, and plurality through diverse teams and markets. The company provides personalized advisory services, optimizing time and resources for clients from start to finish of transactions.
Company description Cyclica official website
Primary marketDrug Discovery & Development
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Cyclica?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
No clinical focus areas are currently listed.
Who it serves
- Construction Companies
- Equipment Rental Companies
- Heavy Machinery Dealers
- Industrial Equipment Buyers
Deployment & integration
Deployment information is currently being developed.
Geographic context
MarketsAlbania · Bosnia and Herzegovina · Chile · Croatia · Dominican Republic · Italy · Macedonia · Montenegro · Netherlands · Portugal · Saudi Arabia · Serbia · Slovenia · Spain · USA
Company sourceOfficial website
Company milestones
Platform expansion
Inventory expansion to 6,675+ products across 450+ references with international distribution network
Partnerships
Recorded partners
- CATERPILLAR
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
No source-backed Company products are currently listed.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Modulation of iron metabolism by new chemicals interacting with the iron regulatory system.Redox biology · Feb 1, 2025
Biased Deep Learning Methods in Detection of COVID-19 Using CT Images: A Challenge Mounted by Subject-Wise-Split ISFCT Dataset.Journal of imaging · Aug 8, 2023
Synthesis of Carvone Derivatives and In Silico and In Vitro Screening of Anti-Inflammatory Activity in Murine Macrophages.International journal of molecular sciences · Jan 23, 2023
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemia.Blood · Jul 7, 2022
SS-4 is a highly selective small molecule inhibitor of STAT3 tyrosine phosphorylation that potently inhibits GBM tumorigenesis in vitro and in vivo.Cancer letters · May 1, 2022
Novel structural-related analogs of PFI-3 (SRAPs) that target the BRG1 catalytic subunit of the SWI/SNF complex increase the activity of temozolomide in glioblastoma cells.Bioorganic & medicinal chemistry · Jan 1, 2022
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
No linked records are currently available.
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Updates from Cyclica
Recent articles published on Cyclica's official website.
07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Drug Discovery & Development
Companies using AI, machine learning, or computational biology to discover new drug candidates, identify drug targets, predict drug efficacy, or accelerate pharmaceutical development. Includes both small molecule and biologics development, precision oncology drug discovery, and AI-driven target identification and molecule design.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.